Purpose
The purpose of the NRG Oncology Lung Cancer Committee is to pursue novel therapeutic strategies toward improving progression-free and overall survival and quality of life for patients with non-metastatic disease.
The Committee's Research priorities include optimizing therapy for patients with both early-stage and locally-advanced lung cancers. Early-stage NSCLC is a heterogeneous patient population, in terms of radiation dose, organs-at-risk, and systemic therapy management. The prognosis for patients with both locally advanced small cell and non-small cell lung cancer is rapidly improving, with the need for further individualized treatment strategies to optimize outcomes based on molecular and anatomical characteristics.
This Committee meets via monthly conference calls and in-person at the NRG Meetings.